Pharmacogenomics (PGx), the study of inherited genomic variation and drug response or
safety, is a vital tool in precision medicine. In oncology, testing to identify PGx variants offers …

Background The fertility of female kidney transplant recipients is increasing with the
progression of transplant management. This article aims to evaluate the clinical prognosis of …

Omics sciences study the whole complex of a specific type of biological molecules within an
organism, be it DNA (genomics), RNA (transcriptomics) to the entire class of proteins …

Background: The presence of polymorphisms in the TPMT gene is associated with adverse
effects in patients treated with standard doses of thiopurine drugs. Scientific evidence …

Recent advancements in genomic sciences and precision medicine have led to improved
regulatory guidance for pharmacogenomics, particularly in the field of cancer therapies …

Background: Pharmacogenetic testing in clinical settings has improved the safety and
efficacy of drug treatment. There is a growing number of studies evaluating …

With the continuing evolution of treatments and therapeutic targets for ulcerative colitis (UC),
the outlook for patients with this condition has improved greatly in recent years. GPs are a …

A third of patients develop severe or life-threatening toxicities from fluoropyrimidines, a
commonly prescribed chemotherapeutic. Fluoropyrimidine toxicity is often due to variation in …